ArticleCancer research2016

Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.

Dashnamoorthy Ravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.